Back to Search
ALLAN PANTUCK, MD
MD
Urology Physician
NPI: 1386663227IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
G85029(CA)
Surgical Oncology Physician
Surgery — Surgical Oncology
Code: 2086X0206X
G85029(CA)
CMS Specialties
PrimaryUROLOGY
Education
OTHER
Class of 1993
Research & Publications (20)
Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma.
PMID 18464292·Int J Cancer·2008
8-other
A novel resectoscope for transurethral resection of bladder tumors and the prostate.
PMID 17936809·J Urol·2007
8-other
Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy.
PMID 17440983·Cancer·2007
8-other
Editorial comment on: Collecting duct renal cell carcinoma: a matched analysis of 41 cases.
PMID 17336450·Eur Urol·2007
8-other
Cytoreductive nephrectomy for metastatic renal cell carcinoma: is it still imperative in the era of targeted therapy?
PMID 17255295·Clin Cancer Res·2007
6-review
Mammalian target of rapamycin inhibitors in renal cell carcinoma: current status and future applications.
PMID 17045090·Semin Oncol·2006
6-review
Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer.
PMID 16818701·Clin Cancer Res·2006
3-trial
Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway.
PMID 14581333·Clin Cancer Res·2003
6-review
Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy.
PMID 12784334·Cancer·2003
8-other
Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
PMID 12771723·J Urol·2003
8-other
Optimizing prostate cancer suicide gene therapy using herpes simplex virus thymidine kinase active site variants.
PMID 11975845·Hum Gene Ther·2002
7-preclinical
CL1-SR39: A noninvasive molecular imaging model of prostate cancer suicide gene therapy using positron emission tomography.
PMID 12187266·J Urol·2002
7-preclinical
Cryosurgical ablation of renal tumors using 1.5-millimeter, ultrathin cryoprobes.
PMID 11796298·Urology·2002
5-case
Biology of renal cell carcinoma: changing concepts in classification and staging.
PMID 11354536·Semin Urol Oncol·2001
6-review
New biologicals for prostate cancer prevention: Genes, vaccines, and immune-based interventions.
PMID 11295604·Urology·2001
6-review
Gene therapy for prostate cancer at the University of California, Los Angeles: preliminary results and future directions.
PMID 10854150·World J Urol·2000
6-review
Intermittent androgen deprivation therapy: schedule modifications based on a novel in vivo human xenograft model.
PMID 12497078·Prostate Cancer Prostatic Dis·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 UCLA MEDICAL PLZ STE 140
LOS ANGELES, CA 90095 - Phone
- (310) 794-7152
Quick Facts
- NPI
- 1386663227
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile